Imaging of salivary gland tumors

Cancer Imaging

Volumn 7, Issue 1, 2007, Pages 52-62

  Thoeny, Harriet C ^a  

^a UNIVERSITY OF BERN   (Switzerland)

Author keywords

Imaging; Magnetic resonance; Salivary glands

Indexed keywords

CHOLINE; CONTRAST MEDIUM; CREATININE;

ACINAR CELL CARCINOMA; ADENOID CYSTIC CARCINOMA; ADENOSQUAMOUS CARCINOMA; ASPIRATION BIOPSY; BRANCHIOGENIC CYST; CANCER CLASSIFICATION; CANCER RADIOTHERAPY; CANCER STAGING; CLINICAL EXAMINATION; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; DIAGNOSTIC PROCEDURE; DIFFERENTIAL DIAGNOSIS; DIFFUSION WEIGHTED IMAGING; HEMANGIOMA; HUMAN; IMAGE ANALYSIS; IMAGE DISPLAY; IMAGE QUALITY; IMAGING SYSTEM; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; LYMPHANGIOMA; LYMPHOMA; MEDICAL DECISION MAKING; NECK DISSECTION; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PAROTID GLAND CANCER; PAROTIDECTOMY; PATHOLOGICAL ANATOMY; PLEOMORPHIC ADENOMA; POSTOPERATIVE PERIOD; PREOPERATIVE EVALUATION; PROGNOSIS; RADIOLOGIST; REVIEW; SALIVARY GLAND; SALIVARY GLAND CANCER; SALIVARY GLAND TUMOR; SENSITIVITY AND SPECIFICITY; WARTHIN TUMOR; ADULT; CHILD; ECHOGRAPHY; FEMALE; HISTOLOGY; METHODOLOGY; PREGNANCY; SALIVARY GLAND DISEASE; SIALOGRAPHY;

ADULT; CHILD; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; PREGNANCY; SALIVARY GLAND DISEASES; SALIVARY GLAND NEOPLASMS; SALIVARY GLANDS; SIALOGRAPHY;

EID: 34249689243     PISSN: None     EISSN: 14707330     Source Type: Journal    
DOI: 10.1102/1470-7330.2007.0008     Document Type: Review

References (38)

1. Som PM, Curtin HD. Head and neck imaging; 2: 3rdSt. Louis, MO: Mosby; 1996, p. 877-912.
2. Batsakis JG. Tumors of the head and neck: clinical and pathological considerations2ndBaltimore, MD: Williams & Willkins; 1979, p. 1-120.
3. Lowe LH, Stokes LS, Johnson JE et al. Swelling at the angle of the mandible: imaging of the pediatric parotid gland and periparotid region. Radiographics 2001; 21: 1211-27.
4. Divi V, Fatt MA, Teknos TN, Mukherji SK. Use of cross-sectional imaging in predicting surgical location of parotid neoplasms. J Comput Assist Tomogr 2005; 29: 315-19.
5. Freling NJ, Molenaar WM, Vermey A et al. Malignant parotid tumors: clinical use of MR imaging and histologic correlation. Radiology 1992; 185: 691-6.
6. Witten J, Hybert F, Hansen HS. Treatment of malignant tumors in the parotid glands. Cancer 1990; 65: 2515-20.
7. Pederson D, Overgaard J, Sogaard H, Elbond O, Overgaard M. Malignant parotid tumors in 110 consecutive patients: treatment results and prognosis. Laryngoscope 1992; 102: 1064-9.
8. Zbaren P, Schupbach J, Nuyens M, Stauffer E, Greiner R, Hausler R. Carcinoma of the parotid gland. Am J Surg 2003; 186: 57-62.
9. Gritzmann N, Rettenbacher T, Hollerweger A. Macheiner P, Hubner E. Sonography of the salivary glands. Eur Radiol 2003; 13: 964-75.
10. Yousem DM, Kraut MA, Chalian AA. Major salivary gland imaging. Radiology 2000; 216: 19-29.
11. Parker GD, Harnsberger HR. Clinical-radiologic issues in perineural tumor spread of malignant diseases of the extracranial head and neck. Radiographics 1991; 11: 383-99.
12. Barakos JA, Dillon WP, Chem WM. Orbit, skull base, and pharynx: contrast-enhanced fat suppression MR imaging. Radiology 1991; 179: 191-8.
13. Yabuuchi H, Fukuya T, Tajima T, Hachitanda Y, Tomita K, Koga M. Salivary gland tumors: diagnostic value of gadolinium-enhanced dynamic MR imaging with histopathologic correlation. Radiology 2003; 226: 345-54.
14. Wang J, Takashima S, Takayama F et al. Head and neck lesions: characterization with diffusion-weighted echo-planar MR imaging. Radiology 2001; 220: 621-30.
15. Habermann CF, Gossrau P, Graessner J et al. Diffusion-weighted echo-planar MRI: a valuable tool for differentiating primary parotid gland tumors? RoFo 2005; 177: 940-5.
16. King AD, Yeung DK, Ahuia AT et al. Salivary gland tumors at in vivo proton MR spectroscopy. Radiology 2005; 237: 563-9.
17. Motoori K, Yamamoto S, Ueda T et al. Inter- and intratumoral variability in magnetic resonance imaging of pleomorphic adenoma: an attempt to interpret the variable magnetic resonance findings. J Comput Assist Tomogr 2004; 28: 233-46.
18. Thoeny HC, De Keyzer F, Boesch C, Hermans R. Diffusion-weighted imaging of the parotid gland: influence of the choice of b-values on the apparent diffusion coefficient value. J Magn Reson Imaging 2004; 20: 786-90.
19. Harnsberger HR. Handbook of head and neck imaging2ndSt. Louis, MO: Mosby; 1990, p. 60-73.
20. Yerli H, Teksam M, Aydin E, Coskun M, Ozdemir H, Agildere AM. Basal cell adenoma of the parotid gland: dynamic CT and MRI findings. Br J Radiol 2005; 78: 642-5.
21. Lee MW, Nam SY, Choi HJ, Choi JH, Moon KC, Koh JK. Myoepithelioma of parotid gland presenting as infra-auricular subcutaneous mass. J Cutan Pathol 2005; 32: 240-4.
22. Sigal R, Monnet O, De Baere T et al. Adenoid cystic carcinoma of the head and neck: evaluation with MR imaging and clinical-pathologic correlation in 27 patients. Radiology 1992; 184: 95-101.
23. Batsakis JG, Luna MA. el-Naggar AK. Histopathologic grading of salivary gland neoplasms: II. Acinic cell carcinomas. Ann Otol Rhinol Laryngol 1990; 99: 929-33.
24. Spiro RH, Huvos AG, Strong EW. Acinic cell carcinoma of salivary origin. A clinicopathologic of 67 cases. Cancer 1978; 41: 924-35.
25. Laskawi R, Rodel R, Zirk A, Arglebe C. Retrospectively analysis of 35 patients with acinic cell carcinoma of the parotid gland. J Oral Maxillofac Surg 1998; 56: 440-3.
26. Suh S, Seol HY; Kim TK, et al. Acinic cell carcinoma of the head and neck: radiology-pathologic correlation. J Comput Assist Tomogr 2005; 29: 121-6.
27. Batsakis JG, Chinn EK, Weimert TA, Work WP, Krause CJ. Acinic cell carcinoma: a clinicopathologic study of thirty-five cases. J Laryngol Otol 1979; 93: 325-40.
28. Motoori K, Iida Y, Nagai Y et al. MR imaging of salivary duct carcinoma. AJNR Am J Neuroradiol 2005; 26: 1201-6.
29. Harish K. Management of primary malignant epithelial parotid tumors. Surg Oncol 2004; 13: 7-16.
30. Witt RL. Major.,salivary gland cancer. Surg Oncol Clin N Am 2004; 13: 113-27.
31. Vander Poorten VL, Balm AJM, Hilgers FJM. Management of cancer of the parotid gland. Curr Opin Otolaryngol Head Neck Surg 2002; 10: 134-44.
32. Guntinas-Lichius O, Klussman JP, Schroeder U, Quante G, Jungehuelsing M, Stennert E. Primary parotid malignoma surgery in patients with normal preoperative facial nerve function: outcome and long-term postoperative facial nerve function. Laryngoscope 2004; 114: 949-56.
33. Spiro RH, Armstrong J, Harrison L, Geller HL, Lin SY, String EW. Carcinoma of major salivary glands. Recent trends. Arch Otolaryngol Head Neck Surg 1989; 115: 316-21.
34. Armstrong JG, Harrison LB, Thaler HT et al. The indications for elective treatment of the neck in cancer of the major salivary glands. Cancer 1992; 69: 615-19.
35. Medina JE. Neck dissection in the treatment of cancer of major salivary glands. Otolaryngol Clin North Am 1998; 31: 815-22.
36. Tran L, Sadeghi A, Hanson D et al. Major salivary gland tumors: treatment results and prognostic factors. Laryngoscope 1986; 96: 1139-44.
37. Tullio A, Marchetti C, Sesenna E, Brusati R, Cocchi R, Eusebi V. Treatment of carcinoma of the parotid gland: the results of a multicenter study. J Oral Maxillofac Surg 2001; 59: 263-70.
38. Zbaren P, Schupbach J, Nuyens M, Stauffer E. Elective neck dissection versus observation in primary parotid carcinoma. Otolaryngol Head Neck Surg 2005; 132: 387-91.